Analysis of Effects of Comprehensive Intervention on the Clinical Application of National Key Monitoring Drugs

WANG Yuan; XU Wei; CUI Yonghua; WANG Yong

doi:10.14009/j.issn.1672-2124.2020.06.024

您当前的位置：

首页 >

文章列表页 >

Analysis of Effects of Comprehensive Intervention on the Clinical Application of National Key Monitoring Drugs

更新时间：2022-10-08

- Analysis of Effects of Comprehensive Intervention on the Clinical Application of National Key Monitoring Drugs
- Vol. 20, Issue 6, Pages: 729-733(2020)
- 作者机构：
  
  1. 南通大学医学院
  2. 南通大学附属建湖医院神经外科
  3. 南通大学附属建湖医院药学部
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2020.06.024
  CLC： R95
- Published：2020，
扫描看全文
[1]王源,许伟,崔永华,王永.综合干预国家重点监控药品临床应用的成效分析[J].中国医院用药评价与分析,2020,20(06):729-733.

WANG Yuan, XU Wei, CUI Yonghua, et al. Analysis of Effects of Comprehensive Intervention on the Clinical Application of National Key Monitoring Drugs. [J]. 20(6):729-733(2020)
[1]王源,许伟,崔永华,王永.综合干预国家重点监控药品临床应用的成效分析[J].中国医院用药评价与分析,2020,20(06):729-733. DOI： 10.14009/j.issn.1672-2124.2020.06.024.

WANG Yuan, XU Wei, CUI Yonghua, et al. Analysis of Effects of Comprehensive Intervention on the Clinical Application of National Key Monitoring Drugs. [J]. 20(6):729-733(2020) DOI： 10.14009/j.issn.1672-2124.2020.06.024.

摘要

目的:了解南通大学附属建湖医院（以下简称"该院"）国家重点监控药品使用情况

为深化改进重点监控药品的临床应用提供参考。方法:该院运用考核、审核、点评及预警系列措施进行干预

并对干预前（2018年第4季度）和干预后（2019年第4季度）重点监控药品的销售金额、用药频度（defined daily dose system

DDDs）、使用率及合理性、规范性进行统计分析。结果:干预后

该院重点监控药品的销售金额占药品总销售金额的比例由干预前的4. 38%（2 025 737. 50元/46 237 198. 20元）降至2. 75%（1 451 480. 20元/52 795 033. 57元）

DDDs同比减少4 730. 5（干预前为18 355. 0

干预后为13 624. 5）

其中活血化瘀类药物降幅最大;住院患者使用率由干预前的25. 5%（436/1 713）降至7. 2%（154/2 152）;适应证不适宜情况改善显著

适应证不适宜病例所占比例由干预前的20. 4%（89/436）降至7. 1%（11/154）。结论:该院综合干预措施可行有效

能够保障国家重点监控药品的临床应用安全、有效和经济。

Abstract

OBJECTIVE: To investigate the clinical application of national key monitoring drugs in Jianhu Hospital Affiliated to Nantong University（ hereinafter referred to as "the hospital"）

so as to provide reference for further improving the clinical application of key monitoring drugs. METHODS: Interventions were performed in the hospital by using a series of assessment

audit

review and early warning measures. Statistical analysis was conducted on consumption sum

defined daily dose system（ DDDs）

application rate and rationality

standardability of key monitoring drugs before intervention（ the 4 th quarter of 2018） and after intervention（ the 4 th quarter of 2019）.RESULTS: After intervention

the proportion of consumption sum of key monitoring drugs to the total drugs decreased from 4. 38%（ 2 025 737. 50 yuan/46 237 198. 20 yuan） before intervention to 2. 75%（ 1 451 480. 20 yuan/52 795 033. 57 yuan） after intervention

DDDs decreased by 4 730. 5 year on year（ 18 355. 0 before intervention and13 624. 5 after intervention）

among which drugs for promoting blood circulation and removing blood stasis showed the greatest decrease. The application rate of antibiotics in inpatients decreased from 25. 5%（ 436/1 713） before intervention to 7. 2%（ 154/2 152） after intervention. There was significant improvement in inappropriate indications

with the proportion decreased from 20. 4%（ 89/436） before intervention 7. 1%（ 11/154） after intervention.CONCLUSIONS: The comprehensive intervention measures of the hospital are feasible and effective

and can ensure the safety

effectiveness and economy of the clinical application of national key monitoring drugs.

关键词

重点监控药品临床应用干预分析

Keywords

Key monitoring drugsClinical applicationInterventionAnalysis

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Investigation and Analysis of Clinical Application of Human Albumin Injection in Inpatients of Beijing Hospital from 2019 to 2020

Analysis on Rationality of 6 000 Discharge Prescriptions with Drugs

Explanation, Source and Clinical Application of Prescription of Mongolian Medicine Qiwei Guangzao Pills

Application of Asarum in 1004 Traditional Chinese Medicine Decoction Pieces and Its Clinical Application in the Treatment of Skin Diseases

Statistical Analysis on Application of Chinese Patent Medicine by Western Clinicians in A General Hospital Based on Information System and Questionnaire Survey

Related Author

王志宏

杨子贤

李朗

ZHANG Jingming

WU Xiaolan

HUANG Fang

SHEN Fuming

文娟

Related Institution

Beijing Hospital

Dept.of Pharmacy,the Tenth People’s Hospital Affiliated to Tongji University

内蒙古民族大学临床医(蒙医)学院

内蒙古民族大学附属医院蒙药检测与研发研究实验室

Mongolian Medicine), Inner Mongolian Minzu University

⁰